Michigan Alcohol Improvement Network- Alcohol Reduction and Treatment Trial
Completed · Not applicable
Conditions studied: Alcohol-Related Disorders, Liver Diseases
In brief
The purpose of the study is to determine if providing participants with alcohol-related liver disease with tailored alcohol use treatment options is feasible and acceptable in order to increase their engagement with treatment and reduce alcohol use. This is an important area to study to help create ways to increase participants' knowledge about different treatment options as well as increase likelihood of seeking and participating in alcohol use disorder treatments.
Key facts
- Study ID
- NCT04473482
- Run by
- University of Michigan
- People needed
- 60
- Starts
- 2020-09-23
- Expected to finish
- 2022-06-30
- Last updated by the study team
- 2023-08-30
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Enrolled at University of Michigan general hepatology clinics or inpatient wards
- Documented diagnosis of alcohol-associated cirrhosis or alcoholic hepatitis or alcohol-related liver disease of any stage
- Drinking of any amount of alcohol within the 6 months prior to recruitment
- No alcohol use treatment within the past 1 month
- Access to a phone for purposes of follow-up
You may not qualify if…
- Active alcohol use treatment
- Undergoing active evaluation for liver transplantation, is listed for liver transplant, or is post-transplantation.
- Is enrolled in the multidisciplinary alcohol-related liver disease clinic at Michigan Medicine
Where it is running
- The University of Michigan — Ann Arbor, Michigan, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.